For evaluating the importance of LPAR1 in osteosarcoma cell invasion, we established polyclonal LPAR1 KO MG-63 cells, designated as sgLPAR1#1-3, using the CRISPR/Cas9 system with 3 different guide RNAs targeting LPAR1. The gene discussed is LPAR1; the disease is osteosarcoma.